학술논문

Is NSTEMI different than STEMI in young patients?
Original Article
Document Type
Academic Journal
Source
Journal of Hypertension Research. April-June 2019, Vol. 5 Issue 2, p91, 8 p.
Subject
Romania
Poland
Language
English
Abstract
Background The leading cause of death in the world, coronary artery disease (CAD), is largely studied worldwide however literature focusing on premature CAD and especially myocardial infarction (MI) is modest [...]
The number of young patients diagnosed with non-ST elevation myocardial infarction (NSTEMI) is increasing and more focused research on their profile and outcome is needed. We analyzed and compared data from 173 patients younger than 45 years of age, 139 patients with STEMI and 34 with NSTEMI) admitted for AMI between January 2009--December 2011; they were prospectively followed for up to 4 years (mean 3 [+ or -] 1 years). NSTEMI patients were older (41 [+ or -] 4 years vs 39 [+ or -] 5, p=0.02) and had a higher prevalence of dyslipidemia (82% vs 60%, p=0.01) than the young STEMI patients who also had higher levels of troponin I (58 [+ or -] 51 vs 11 [+ or -] 9 ng/ml, p II (in 19% of STEMI vs 15% of NSTEMI patients, p=0.1) and the mean BNP at presentation (313 [+ or -] 452 in STEMI vs 297 [+ or -] 483 pg/ml in NSTEMI patients, p=0.8) were similar. Multivessel atherosclerotic coronary disease (48% of the NSTEMI patients) and significant stenosis of the circumflex artery (56%) were more frequent in the young NSTEMI group. The PCI rate was significantly higher in the STEMI group (87% vs 68%, p Keywords: young, myocardial, infarction